Weiwei Guo

1.5k total citations
42 papers, 717 citations indexed

About

Weiwei Guo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Weiwei Guo has authored 42 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Immunology and 7 papers in Oncology. Recurrent topics in Weiwei Guo's work include Immune Cell Function and Interaction (6 papers), Cancer-related molecular mechanisms research (4 papers) and Respiratory viral infections research (4 papers). Weiwei Guo is often cited by papers focused on Immune Cell Function and Interaction (6 papers), Cancer-related molecular mechanisms research (4 papers) and Respiratory viral infections research (4 papers). Weiwei Guo collaborates with scholars based in China and United States. Weiwei Guo's co-authors include Ling Yang, Ji Zuo, Zhi‐Qiang Ling, Xiaoxiao Lu, Da Yang, Yan Chen, Guixia Li, Mengchuan Zhao, Zhishan Feng and Guochun Gong and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Weiwei Guo

40 papers receiving 710 citations

Peers

Weiwei Guo
Mujun Yu United States
Rashed Abdullah United States
Mohammed Kanchwala United States
Patrick T. Reilly United States
Purvi Patel United States
Monica McAndrews United States
Jae Ryoung Hwang South Korea
Ian D. Odell United States
Mujun Yu United States
Weiwei Guo
Citations per year, relative to Weiwei Guo Weiwei Guo (= 1×) peers Mujun Yu

Countries citing papers authored by Weiwei Guo

Since Specialization
Citations

This map shows the geographic impact of Weiwei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Guo more than expected).

Fields of papers citing papers by Weiwei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Guo. The network helps show where Weiwei Guo may publish in the future.

Co-authorship network of co-authors of Weiwei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Guo. A scholar is included among the top collaborators of Weiwei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Guo. Weiwei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yanhua, et al.. (2024). Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review. BMC Cancer. 24(1). 110–110. 1 indexed citations
2.
Guo, Weiwei, et al.. (2024). Two-Dimensional Hydrodynamic Simulation of the Effect of Stormwater Inlet Blockage on Urban Waterlogging. Water. 16(14). 2029–2029. 2 indexed citations
3.
Zhang, Linliang, Hongyun Wang, Chao Han, et al.. (2024). AMFR-mediated Flavivirus NS2A ubiquitination subverts ER-phagy to augment viral pathogenicity. Nature Communications. 15(1). 9578–9578. 10 indexed citations
4.
Pan, Xiaoyan, et al.. (2023). Active molecule-based theranostic agents for tumor vasculature normalization and antitumor efficacy. Chinese Chemical Letters. 35(8). 109187–109187.
5.
Liu, Kunpeng, Yun Peng, Zhe Ding, et al.. (2022). Recombinant chimpanzee adenovirus vector vaccine expressing the spike protein provides effective and lasting protection against SARS-CoV-2 infection in mice. Virologica Sinica. 37(4). 581–590. 1 indexed citations
6.
Guo, Weiwei, Ghanshyam S. Yadav, Zehua Wang, et al.. (2022). Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response. Science Advances. 8(49). eadd0005–eadd0005. 10 indexed citations
7.
Guo, Weiwei, et al.. (2021). Ebosin Ameliorates Psoriasis-Like Inflammation of Mice via miR-155 Targeting tnfaip3 on IL-17 Pathway. Frontiers in Immunology. 12. 662362–662362. 17 indexed citations
8.
Wu, Zhiyuan, Sihan Li, Xuemei Tang, et al.. (2020). Copy Number Amplification of DNA Damage Repair Pathways Potentiates Therapeutic Resistance in Cancer. Theranostics. 10(9). 3939–3951. 38 indexed citations
9.
Shi, Wei, Qianqian Qiu, Weiwei Guo, et al.. (2020). Synthetic tumor-specific antigenic peptides with a strong affinity to HLA-A2 elicit anti-breast cancer immune response through activating CD8+ T cells. European Journal of Medicinal Chemistry. 189. 112051–112051. 12 indexed citations
10.
Shi, Wei, Qianqian Qiu, Weiwei Guo, et al.. (2020). Novel HLA-A2 restricted antigenic peptide derivatives with high affinity for the treatment of breast cancer expressing NY-ESO-1. Bioorganic Chemistry. 103. 104138–104138. 3 indexed citations
11.
Yao, Shuang, et al.. (2019). Correlation between serum homocysteine, folate, vitamin B6 and age-related cataract. SHILAP Revista de lepidopterología. 30(1). 142–145.
12.
Zhao, Mengchuan, Le Wang, Li Zhao, et al.. (2019). Impact and clinical profiles of Mycoplasma pneumoniae co-detection in childhood community-acquired pneumonia. BMC Infectious Diseases. 19(1). 835–835. 19 indexed citations
13.
You, Xue, Weiwei Guo, Lin Wang, et al.. (2017). Subcellular distribution of RAD23B controls XPC degradation and DNA damage repair in response to chemotherapy drugs. Cellular Signalling. 36. 108–116. 18 indexed citations
14.
Guo, Weiwei, Xue You, Xiao Wang, Lin Wang, & Yan Chen. (2017). A synthetic peptide hijacks the catalytic subunit of class I PI3K to suppress the growth of cancer cells. Cancer Letters. 405. 1–9. 7 indexed citations
15.
Ling, Zhi‐Qiang, Weiwei Guo, Xiaoxiao Lu, et al.. (2015). PAQR3 expression is downregulated in human breast cancers and correlated with HER2 expression. Oncotarget. 6(14). 12357–12368. 20 indexed citations
16.
Guo, Weiwei, Lichong Yan, Ling Yang, et al.. (2014). Targeting GRP75 Improves HSP90 Inhibitor Efficacy by Enhancing p53-Mediated Apoptosis in Hepatocellular Carcinoma. PLoS ONE. 9(1). e85766–e85766. 35 indexed citations
17.
Guo, Weiwei, et al.. (2013). Endoscopic management of blue rubber bleb nevus syndrome: A case report. Experimental and Therapeutic Medicine. 6(5). 1159–1162. 8 indexed citations
18.
19.
Yang, Ling, Weiwei Guo, Qunling Zhang, et al.. (2011). Crosstalk between Raf/MEK/ERK and PI3K/AKT in Suppression of Bax Conformational Change by Grp75 under Glucose Deprivation Conditions. Journal of Molecular Biology. 414(5). 654–666. 54 indexed citations
20.
Zhao, Xingbo, Na Li, Weiwei Guo, et al.. (2004). Further evidence for paternal inheritance of mitochondrial DNA in the sheep (Ovis aries). Heredity. 93(4). 399–403. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026